KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
104 hedge funds and large institutions have $713M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 12 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 32
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
2% more funds holding
Funds holding: 102 → 104 (+2)
1% more capital invested
Capital invested by funds: $704M → $713M (+$8.99M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
53% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $2.47M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$12.8M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$7.7M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.15M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$4.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$6.98M |
| 2 |
Renaissance Technologies
New York
|
-$4.63M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.29M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$3.26M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$2.98M |
KYTH Hedge Fund Activity: Q2 2014 in Review
104 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q2 2014, worth a combined $713M — up 1.3% from $704M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new KYTH positions and 12 closed out — a net gain of 2 holders — while 50 added to existing stakes and 32 trimmed.
The largest buyer was Jennison Associates, adding an estimated $12.8M. The largest seller was Waddell & Reed Financial, cutting an estimated $6.98M.
- 104 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q2 2014, up from 102 in Q1 2014.
- Funds reported $713M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q2 2014, up 1.3% quarter-over-quarter.
- 14 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q2 2014 and 12 closed out, a net change of +2 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q2 2014 was Jennison Associates, an estimated $12.8M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q2 2014 was Waddell & Reed Financial, an estimated $6.98M sold.
Based on aggregated 13F filings for Q2 2014.